AbbVie
ABBV
#32
Rank
$287.34 B
Marketcap
$162.28
Share price
-2.22%
Change (1 day)
0.56%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of December 2023 : $124.31 B

According to AbbVie's latest financial reports the company's total liabilities are $124.31 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31$124.31 B2.3%
2022-12-31$121.51 B-7.3%
2021-12-31$131.09 B-4.64%
2020-12-31$137.46 B41.3%
2019-12-31$97.28 B43.5%
2018-12-31$67.79 B3.21%
2017-12-31$65.68 B6.88%
2016-12-31$61.46 B25.17%
2015-12-31$49.10 B90.54%
2014-12-31$25.77 B4.31%
2013-12-31$24.70 B4.49%
2012-12-31$23.64 B211.57%
2011-12-31$7.58 B39.72%
2010-12-31$5.43 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$137.21 B 10.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$53.14 B-57.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$90.92 B-26.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.04 B-90.31%๐Ÿ‡บ๐Ÿ‡ธ USA
$39.37 B-68.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$65.67 B-47.17%๐Ÿ‡บ๐Ÿ‡ธ USA
$61.95 B-50.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
$58.82 B-52.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
$1.01 B-99.18%๐Ÿ‡บ๐Ÿ‡ธ USA